Treatment News : CDC Recommends HPV Vaccine for Boys and Young Men, Hep B Vaccine for Diabetics

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Treatment News » February 2012

Most Popular Links
Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

20 Years Ago In POZ

More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to


February 6, 2012

CDC Recommends HPV Vaccine for Boys and Young Men, Hep B Vaccine for Diabetics

It’s official: All males between 11 and 21 years of age should be vaccinated against human papillomavirus (HPV), a leading cause of oral, genital and anal cancers, according to new U.S. Centers for Disease Control and Prevention guidelines published February 3 in the health agency’s Morbidity and Mortality Weekly Report. HPV vaccination is also recommended for previously unvaccinated men between 22 and 26 years of age who have compromised immune systems, are HIV positive or have sex with other men.

The CDC is also officially recommending hepatitis B virus (HBV) vaccination for all adults younger than 60 who have diabetes, as soon as possible after diabetes is diagnosed. In addition, HBV vaccination is recommended at the discretion of health care providers for adults with diabetes who are 60 or older, based on the person’s likely need for assisted blood glucose monitoring, likelihood of acquiring the virus and likelihood of an effective immune response following vaccination.

The published guidelines follow an October 26, 2011, vote by the CDC’s Advisory Committee on Immunization Practices (ACIP) to recommend major changes in the use of Gardasil, one of the two major HPV vaccines approved to date. Whereas Merck’s Gardasil has been approved by the U.S. Food and Drug Administration (FDA) for boys and young men ages 9 to 26, based on data concluding that it protects against 90 percent of genital warts cases, GlaxoSmithKline’s Cervarix is only approved for the prevention of cervical cancer and precancerous lesions in females.

ACIP also voted to recommend the HBV vaccination for all adults with diabetes who are younger than 60 and who have not previously received the vaccine. The recommendation was based on evidence that people living with diabetes are at increased risk for HBV because of shared testing equipment.

Search: human papillomavirus, HPV, hepatitis B virus, HBV, vaccine, immunization, CDC, ACIP, recommendations, guidelines, MMWR, boys, men, diabetes

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (0 total)

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Has a pet helped you deal with your HIV?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.